For years, scholars suspected that talcum powder was related to ovarian cancer. They surmise that small quantities of talcum powder used for female cleanliness purposes ultimately moved through their organs and the fallopian tubes to the ovaries.
Several producers changed the formulation of their products to eliminate talcum powder, but Johnson & Johnson continued to use it in its Baby Powder and Shower to Shower products. Johnson & Johnson also failed to warn users of the risks of talcum powder and its link to ovarian cancer, despite increasing evidence of its dangers. Instead, the company chose to withhold that information. You can read about talcumpowdercancerlawsuit via online sources
This disinclination by Johnson & Johnson to disclose the known risks of its products follows a pattern. The company is also deeply involved litigation involving Risperdal and vaginal mesh products. Johnson & Johnson’s reluctance to disclose the risks of talcum powder is yet one more example of corporate greed taking precedence over the health of its customers.
Asbestos has been implicated in causing mesothelioma and although it has been used for hundreds, if not thousands of years, it has only been carefully restricted in recent decades. Asbestos is a fibrous silicate mineral, like talc. It has a lot of properties that have made it so useful over the years.
It’s not unusual to hear about mesothelioma lawsuits, as asbestos has been used in so many places and a lot of workers have been exposed to it and came down with this terrible cancer. Lawsuits over mesothelioma caused by talcum powder have been much less common. This may change as more research finds that asbestos particles have contaminated these products that so many people use regularly.
Though Johnson & Johnson denies any risk associated with talcum powder products, a recent study suggests otherwise. In a report published with the U.S. National Library of Medicine, researchers state that people who used what they referred to as genital talc were at an increased risk for developing ovarian cancer of 33 percent.Click here for more information.